BHC
Price
$4.63
Change
-$0.01 (-0.22%)
Updated
Jun 5 closing price
Capitalization
3.86B
54 days until earnings call
CRON
Price
$1.91
Change
-$0.02 (-1.04%)
Updated
Jun 5 closing price
Capitalization
1B
62 days until earnings call
Interact to see
Advertisement

BHC vs CRON

Header iconBHC vs CRON Comparison
Open Charts BHC vs CRONBanner chart's image
Bausch Health Companies
Price$4.63
Change-$0.01 (-0.22%)
Volume$723.52K
Capitalization3.86B
Cronos Group
Price$1.91
Change-$0.02 (-1.04%)
Volume$2.03M
Capitalization1B
BHC vs CRON Comparison Chart
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. CRON commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a StrongBuy and CRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (BHC: $4.63 vs. CRON: $1.91)
Brand notoriety: BHC: Notable vs. CRON: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 34% vs. CRON: 111%
Market capitalization -- BHC: $3.86B vs. CRON: $1B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green whileCRON’s FA Score has 0 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • CRON’s FA Score: 0 green, 5 red.
According to our system of comparison, BHC is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 4 TA indicator(s) are bullish while CRON’s TA Score has 6 bullish TA indicator(s).

  • BHC’s TA Score: 4 bullish, 2 bearish.
  • CRON’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BHC and CRON are a good buy in the short-term.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а +0.43% price change this week, while CRON (@Pharmaceuticals: Other) price change was -6.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.45%. For the same industry, the average monthly price growth was +14.82%, and the average quarterly price growth was +63.61%.

Reported Earning Dates

BHC is expected to report earnings on Jul 30, 2025.

CRON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than CRON($1.01B). CRON YTD gains are higher at: -5.446 vs. BHC (-42.556). BHC has higher annual earnings (EBITDA): 2.2B vs. CRON (-71.8M). BHC has more cash in the bank: 947M vs. CRON (862M). CRON has less debt than BHC: CRON (2.55M) vs BHC (22.4B). BHC has higher revenues than CRON: BHC (8.76B) vs CRON (87.2M).
BHCCRONBHC / CRON
Capitalization3.86B1.01B384%
EBITDA2.2B-71.8M-3,067%
Gain YTD-42.556-5.446781%
P/E Ratio13.39N/A-
Revenue8.76B87.2M10,042%
Total Cash947M862M110%
Total Debt22.4B2.55M877,399%
FUNDAMENTALS RATINGS
BHC vs CRON: Fundamental Ratings
BHC
CRON
OUTLOOK RATING
1..100
573
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9984
PRICE GROWTH RATING
1..100
8860
P/E GROWTH RATING
1..100
9880
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (33) in the Pharmaceuticals Other industry is in the same range as CRON (54). This means that BHC’s stock grew similarly to CRON’s over the last 12 months.

BHC's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRON (100). This means that BHC’s stock grew similarly to CRON’s over the last 12 months.

CRON's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as BHC (99). This means that CRON’s stock grew similarly to BHC’s over the last 12 months.

CRON's Price Growth Rating (60) in the Pharmaceuticals Other industry is in the same range as BHC (88). This means that CRON’s stock grew similarly to BHC’s over the last 12 months.

CRON's P/E Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as BHC (98). This means that CRON’s stock grew similarly to BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCCRON
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 8 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGVFX33.980.04
+0.12%
Polaris Global Value
FCVCX15.25N/A
N/A
Fidelity Advisor Small Cap Value C
CVMCX18.38N/A
N/A
Calvert Emerging Markets Equity C
VFFSX292.74N/A
N/A
Vanguard 500 Index Institutional Select
WBCRX15.81-0.05
-0.32%
William Blair Small-Mid Cap Core R6

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-1.04%
SNDL - CRON
73%
Closely correlated
N/A
TLRY - CRON
60%
Loosely correlated
-5.40%
OGI - CRON
59%
Loosely correlated
-2.24%
ACB - CRON
58%
Loosely correlated
-2.93%
CGC - CRON
58%
Loosely correlated
+5.38%
More